Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Pasithea Therapeutics Corp. - Common Stock (NQ:KTTA)

1.270 +0.080 (+6.72%)
Streaming Delayed Price Updated: 3:51 PM EDT, Apr 3, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 95,750
Open 1.180
Bid (Size) 1.210 (2)
Ask (Size) 1.290 (1)
Prev. Close 1.190
Today's Range 1.140 - 1.290
52wk Range 0.9226 - 9.250
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Thursday's session: top gainers and losers
Curious to know what's happening on the US markets in the middle of the day on Thursday? Join us as we explore the top gainers and losers in today's session. 
Via Chartmill
Thursday's session: gap up and gap down stocks
The market is filled with gapping stocks in Thursday's session. Let's discover which stocks are showing gap-ups and gap-downs. 
Via Chartmill

Performance

YTD
-56.7%
-56.7%
1 Month
+15.5%
+15.5%
3 Month
-56.7%
-56.7%
6 Month
-74.1%
-74.1%
1 Year
-82.4%
-82.4%

More News

Read More
Which stocks are moving before the opening bell on Thursday?
Via Chartmill
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
These stocks are moving in today's after hours session
Via Chartmill
Crude Oil Down 2%; ISM Services PMI Falls In January
Via Benzinga
Exposures Fossil Fuels
US Stocks Mixed; Walt Disney Posts Upbeat Earnings
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
Dow Surges Over 250 Points; Accenture Earnings Top Views
Via Benzinga
Topics Stocks
Exposures US Equities
12 Health Care Stocks Moving In Thursday's Intraday Session
Via Benzinga
Crude Oil Down Over 2%; US Initial Jobless Claims Fall
Via Benzinga
Exposures Fossil Fuels
Nasdaq Gains Over 1%; Micron Posts Upbeat Q4 Results
Via Benzinga
Why Is Pasithea Therapeutics Stock Surging On Thursday?
Via Benzinga
KTTA Stock Earnings: Pasithea Therapeutics Reported Results for Q2 2024
Via InvestorPlace
KTTA Stock Earnings: Pasithea Therapeutics Reported Results for Q4 2023
Via InvestorPlace
12 Health Care Stocks Moving In Tuesday's Intraday Session
Via Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
Via Benzinga
KTTA Stock Earnings: Pasithea Therapeutics Reported Results for Q1 2024
Via InvestorPlace
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
Via InvestorPlace
12 Health Care Stocks Moving In Monday's Intraday Session
Via Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
RBLX Stock Alert: Wells Fargo Initiates Roblox Coverage With ‘Overweight’ Rating
Via InvestorPlace
PLTR Stock: Palantir Renews UniCredit Partnership
Via InvestorPlace
Why Is ReShape Lifesciences (RSLS) Stock Up 68% Today?
Via InvestorPlace
Exposures Product Safety

Frequently Asked Questions

Is Pasithea Therapeutics Corp. - Common Stock publicly traded?
Yes, Pasithea Therapeutics Corp. - Common Stock is publicly traded.
What exchange does Pasithea Therapeutics Corp. - Common Stock trade on?
Pasithea Therapeutics Corp. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Pasithea Therapeutics Corp. - Common Stock?
The ticker symbol for Pasithea Therapeutics Corp. - Common Stock is KTTA on the Nasdaq Stock Market
What is the current price of Pasithea Therapeutics Corp. - Common Stock?
The current price of Pasithea Therapeutics Corp. - Common Stock is 1.270
When was Pasithea Therapeutics Corp. - Common Stock last traded?
The last trade of Pasithea Therapeutics Corp. - Common Stock was at 04/03/25 03:51 PM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.